TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug (IL-6 ligand mAb) targeting inflammation in CKD with high cardiovascular risk
29 August 2026 (08:45 - 08:55)
Organised by: 
About the speaker
Icahn School of Medicine at Mount Sinai, New York City (United States of America)
17 More presentations in this session
Professor G. Montalescot (Paris, FR)
Access the full session
The Event
ESC Congress 2026
29 August 2026
08:45 CET
You may be interested in
Congress Session
29 August 2022
Congress Presentation
